Heghine Khachatryan on VWD: A Landmark in the History of Hematology
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, sreposted from Haematologica Journal on LinkedIn:
”A Landmark in the History of Hematology
One hundred years ago, the Finnish physician Erik Adolf von Willebrand published his seminal description of hereditary pseudohemophilia, a disorder that would later bear his name as von Willebrand disease.
This groundbreaking work was the first to clearly demonstrate that:
• inherited bleeding disorders may affect both sexes,
• the clinical phenotype can differ fundamentally from classical hemophilia, and
• family-based observation and pedigree analysis are critical to understanding disorders of hemostasis.
-The original genealogical diagram, shown here, represents more than a historical artifact—it laid the scientific foundation for modern concepts of primary hemostasis, platelet–vessel wall interaction, and the role of von Willebrand factor in coagulation.
-A century later, von Willebrand’s observations continue to inform contemporary diagnostics, molecular genetics, and individualized therapeutic strategies in bleeding disorders.
This milestone reminds us that careful clinical observation remains the cornerstone of scientific progress, even in the era of advanced genomics and precision medicine.”
Quoting Haematologica Journal‘s post:
”Landmark paper in Hematology: One hundred years ago the Finnish physician Erik Adolf von Willebrand published his landmark paper on hereditary pseudohemophilia in Documents of the Finnish Society of Medicine: he had discovered the disease that nowadays we universally known by his name.”
Read the full article here.
Article: The landmark contribution by Erik von Willebrand
Authors: Riitta Lassila, Erik Berntorp
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 16, 2026, 18:12Adil Nawaz: Extended Dual Antiplatelet Therapy After Coronary Stenting
-
Oct 16, 2026, 17:50Elad Asher։ STORM-PE Shows Functional Benefits of Thrombectomy
-
Oct 16, 2026, 17:32Shruthi Narayan: STORM-PE and STRIKE-PE Studies Advance Understanding of Recovery After Pulmonary Embolism
-
Oct 16, 2026, 17:22Wolfgang Miesbach։ What a Near-Perfect FISH Score Fails to See
-
Oct 16, 2026, 17:06Troels Wienecke: Connecting Myeloproliferative Disease and Ischemic Stroke
-
Oct 16, 2026, 17:03Only 5 Days Left to Submit Your Research for EAHAD 2027
-
Oct 16, 2026, 16:48Abdul Rahman: Reticulocyte Count and Bone Marrow Activity
-
Oct 16, 2026, 16:44DOAC Adherence in Stroke Patients With Atrial Fibrillation – International Journal of Stroke
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand